Advanced search×

Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome-Bench to Bedside: LXVII Edward Jackson Memorial Lecture

Am J Ophthalmol 151(2):0 (2011) PMID 21168815 PMCID PMC3057105

Purpose: To update information on cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) and to integrate information on its pathogenesis and clinical outcomes. Design: Literature review. Methods: Selected articles from the medical literature, particularly large epidemiologic studies, including the Johns Hopkins Cytomegalovirus Retinitis Cohort Study, the Longitudinal Study of the Ocular Complications of AIDS, and the Cytomegalovirus Retinitis and Viral Resistance Study, were reviewed. Clinical information is discussed in light of knowledge on CMV, its pathogenesis, and its interactions with human immunodeficiency virus (HIV). Results: Cytomegalovirus uses several mechanisms to evade the immune system and establish latent infection in immunologically normal hosts. With immune deficiency, such as late-stage AIDS, CMV reactivates, is disseminated to the eye, and establishes a productive infection, resulting in retinal necrosis. HIV and CMV potentiate each other: CMV accelerates HIV disease, and CMV retinitis is associated with increased mortality. Randomized clinical trials have demonstrated the efficacy of treatments for CMV retinitis. Systemically administered treatment for CMV retinitis decreases AIDS mortality. Highly active antiretroviral therapy (HAART) effectively suppresses HIV replication, resulting in immune recovery, which, if sufficient, controls retinitis without anti-CMV therapy. Resistant CMV, detected in the blood, correlates with resistant virus in the eye and is associated with worse clinical outcomes, including mortality. Host factors, including host genetics and access to care, play a role in the development of CMV retinitis. Conclusions: Clinical outcomes of CMV retinitis in patients with AIDS are dependent on characteristics of the virus and host and on HIV-CMV interactions.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ajo.2010.10.018
Version: za2963e q8za7 q8zb4 q8zce q8zd6 q8zea q8zf0 q8zga

Similar articles you may find interesting…

  1. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from ...

    Sex Transm Infect 86(1):66-70 (2010) PMID 19720603

    These results underscore the need to develop more effective secondary prevention-interventions for HIV-infected MSM, tailored to more recently diagnosed patients, particularly those who are younger and substance users....
  2. Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.

    AIDS Patient Care STDS 16(6):255-67 (2002) PMID 12133261

    Injection drug users represent a major vector of human immunodeficiency virus (HIV) infection in the nation's inner cities, and are an important population for harm reduction treatment interventions to target. However, there has been relatively little research examining the specific contribution of...
  3. A brief HIV stigma reduction intervention for service providers in China.

    AIDS Patient Care STDS 22(6):513-20 (2008) PMID 18462076

    This study assessed the effect of a brief intervention aimed at reducing HIV-related stigma among service providers in China. From December 2005 to June 2006, 138 service providers from four county hospitals in the Yunnan province of China were randomly assigned into either an intervention or a cont...